Karyopharm Therapeutics Inc. - Common Stock (KPTI)

8.1750
+0.4450 (5.76%)
NASDAQ · Last Trade: Mar 20th, 11:30 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Registration Momentum Builds Across the Oncology Pipeline
Issued on behalf of Oncolytics Biotech Inc.
By USA News Group · Via GlobeNewswire · February 17, 2026